{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:18:56Z","timestamp":1790198336301,"version":"4.1.0"},"reference-count":8,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaacap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Child &amp; Adolescent Psychiatry"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.jaac.2019.07.001","type":"journal-article","created":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T07:40:06Z","timestamp":1568014806000},"page":"936-938","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Debate: Are Stimulant Medications for Attention-Deficit\/Hyperactivity Disorder Effective in the Long Term? (Against)"],"prefix":"10.1016","volume":"58","author":[{"given":"James M.","family":"Swanson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaac.2019.07.001_bib1","first-page":"CD009885","article-title":"Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)","volume":"11","author":"Storebo","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaac.2019.07.001_bib2","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S2215-0366(18)30269-4","article-title":"Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis","volume":"5","author":"Cortese","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jaac.2019.07.001_bib3","series-title":"Oxford Textbook of Attention Deficit Hyperactivity Disorder","first-page":"315","article-title":"Long-term outcomes in the multimodal treatment study of ADHD (the MTA): From beginning to end. 2018","author":"Swanson","year":"2018"},{"key":"10.1016\/j.jaac.2019.07.001_bib4","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1176\/appi.ajp.2007.07091486","article-title":"Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up study","volume":"165","author":"Biederman","year":"2008","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaac.2019.07.001_bib5","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jaac.2012.12.014","article-title":"Adolescent substance use in the Multimodal Treatment Study of Attention-Deficit\/Hyperactivity Disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication","volume":"52","author":"Molina","year":"2013","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2019.07.001_bib6","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1056\/NEJMoa1203241","article-title":"Medication for attention deficit-hyperactivity disorder and criminality","volume":"367","author":"Lichtenstein","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaac.2019.07.001_bib7","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.acap.2017.09.005","article-title":"Reasons why children and adolescents with attention-deficit\/hyperactivity disorder stop and restart taking medicine","volume":"18","author":"Brinkman","year":"2018","journal-title":"Acad Pediatr"},{"key":"10.1016\/j.jaac.2019.07.001_bib8","article-title":"Long-term stimulant treatment affects brain dopamine transporter level in patients with attention deficit hyperactive disorder","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"}],"container-title":["Journal of the American Academy of Child &amp; Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856719304502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856719304502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T14:26:35Z","timestamp":1760192795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890856719304502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":8,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0890856719304502"],"URL":"https:\/\/doi.org\/10.1016\/j.jaac.2019.07.001","relation":{},"ISSN":["0890-8567"],"issn-type":[{"value":"0890-8567","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Debate: Are Stimulant Medications for Attention-Deficit\/Hyperactivity Disorder Effective in the Long Term? (Against)","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Child & Adolescent Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaac.2019.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a92019 Published by Elsevier Inc. on behalf of the American Academy of Child and Adolescent Psychiatry.","name":"copyright","label":"Copyright"}]}}